ClinChoice is a full-service clinical CRO dedicated to offering high-quality, efficient and flexible solutions to pharmaceutical, biotechnology, medical device, and consumer products clients worldwide. With a 25 year history of success, ClinChoice continues to be The Standard of Excellence for biostatistics, clinical operations, data management, statistical programming, CDISC, regulatory affairs, medical affairs and pharmacovigilance. ClinChoice has established major delivery centers across US, China, Europe, India, Japan and the Philippines. It has over 1,800 employees globally, with a strong and talented team, and a growing clinical operations presence in seven countries across Asia, North America and Europe.
Location: United States, Pennsylvania, Fort Washington
Employees: 1001-5000
Founded date: 1995
Investors 1
| Date | Name | Website |
| 16.09.2022 | Draper Ass... | draper.vc |
Mentions in press and media 5
| Date | Title | Description |
| 23.03.2026 | Monash University and ClinChoice Forge Strategic Partnership to Accelerate Clinical Development of Innovative Therapies | MELBOURNE, Australia, March 23, 2026 /PRNewswire/ -- Monash University and ClinChoice Inc, a leading global clinical Contract Research Organization (CRO) focused on innovative therapeutics, today announced a strategic partnership designed t... |
| 07.07.2022 | ClinChoice Raises $150M in Series E Funding | ClinChoice, a Philadelphia, PA- and Shangai, China-based clinical CRO company, raised $150M in Series E funding. The round wasted by Legend Capital, with participation from Taikang Life Insurance, Sherpa Healthcare Partners, Lilly Asia Vent... |
| 05.07.2022 | ClinChoice Raises $150 mm Series E Round Financing, Further Strengthening its Global Services Capabilities | PHILADELPHIA, July 5, 2022 /PRNewswire/ -- Recently, ClinChoice announced the successful completion of its $150 mm Series E round financing. The investment was led by Legend Capital, and co-invested by Taikang Life Insurance, Sherpa Healthc... |
| 05.07.2022 | China's Legend Capital leads $150m Series E round in ClinChoice | Legend Capital, a fund management arm of Chinese conglomerate Legend Holdings, has led a $150-million Series E funding round for ClinChoice to help the Sino-US contract research organisation (CRO) expand its business and service offerings g... |
| 17.08.2021 | ClinChoice Names Connie Andrews Vice President of Clinical Operations |